Search

everythinglearnresearchcommunity

for

Search:↓

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The document explains how to identify different hair problems using a microscope.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Blood stem cells are diverse, influenced by many factors, and understanding them is key for progress in regenerative medicine.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Low zinc levels in chronic liver disease patients are linked to more severe symptoms like taste issues and skin problems, and zinc supplements might help.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Pimecrolimus cream is not effective for treating alopecia areata.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.